期刊
HEART FAILURE CLINICS
卷 14, 期 4, 页码 501-+出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.hfc.2018.05.002
关键词
Chronic heart failure; Growth hormone; IGF-1; Anabolic deficiency; Biomarker; Outcomes; Novel therapies; Hormone deficiency
资金
- Cardiopath
Several studies have shown that growth hormone (GH) deficiency is common in chronic heart failure and is associated with impaired functional capacity and poor outcomes. Data derived from animal models showed beneficial effects of GH treatment on peripheral vascular resistance, cardiac function, and survival. Despite this solid background, when translated onto the clinical field, these results did not lead to unequivocal results. This article focuses on the assessment of GH deficiency in chronic heart failure, the underlying molecular background, the impact on disease progression and outcomes, the effects of GH therapy, and the novel and more encouraging approach of GH-replacement therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据